According to GoodRx, compliance rates are high, with only 9% of commercially insured people having full Zepbound coverage and 14% having full Wegovy coverage. This refers to insurance coverage that ...

Pharmacy benefit managers started popping up in the late 1960s as providers of claims processing and administrative services ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

With the festival season of Christmas and New Year's around, tech billionaire Elon Musk shared a photo on his social media ...

Proposed federal dietary recommendations may bring new focus to what it means to eat healthy in 2025, but longstanding ...

According to the FDA, compounding usually involves altering the ingredients of a drug or adding new ingredients. This final ...

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

I have a scam alert for you about a problem rearing its ugly head again as we head into the new year, when health and fitness ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.

With childhood obesity on the rise, some recommend new weight loss medications such as Ozempic ...

Skyrocketing demand for Ozempic ( NVO ), Wegovy and other weight-loss drugs has boosted business for another line of work: ...

Elon Musk took to X on Wednesday to revel in the Christmas spirit. He also reportedly credited Mounjaro for his weight loss.